Order byBest matchMost fresh

Johnson sending House

Digest more
Speaker Johnson Refuses to Allow Epstein Vote as House Set to Recess Early
La., arrives for an early morning strategy session with the Republican Conference, at the Capitol in Washington, Tuesday, July 22, 2025. (AP Photo/J. Scott Applewhite) WASHINGTON (AP) — House Speaker Mike Johnson is rebuffing pressure to act on the investigation into Jeffrey Epstein,

Continue reading

Johnson sending House home early amid Epstein files standoff
Johnson shuts door on House vote before September on releasing Epstein files
House Republicans start recess early to avoid vote on Epstein files
House Speaker Mike Johnson on Tuesday (July 22) said he would send lawmakers home a day early for a five-week summer recess to avoid a political fight over files on disgraced financier and sex offende...

Continue reading

Johnson Shuts Down House Early to Flee Epstein Questions
fox61 · 11h
Speaker Johnson refuses to allow Epstein vote as House set to recess early
Mike Johnson shuts Congress for summer to avoid dealing with Trump handling of Epstein files
Johnson expressed his frustration over what he described as the Democrats’ attempts to weaponize the Rules process, at times pounding his fist on the podium talking about Epstein, attacking the minor...

Continue reading

Epstein files paralyze the House, forcing Johnson to cancel votes and start recess
House ending session early as Republican clash over Epstein vote
Johnson & Johnson Stock Could Be Waking Up
Johnson & Johnson's stock offers value with promising MedTech growth, raised guidance, strong dividends, and bullish technical momentum. Learn more on JNJ stock here.
Johnson & Johnson (JNJ): I Counted 15 Separate Surprises,” Says Jim Cramer
We recently published 10 Stocks Jim Cramer Discussed As He Shared Key Insights From Morgan Stanley’s CEO. Johnson & Johnson (NYSE:JNJ) is one of the stocks Jim Cramer recently discussed. Johnson & Johnson (NYSE:JNJ)’s shares are up by 5% since its latest earnings report,
Explore more
Becker's Spine Review15h
Johnson & Johnson partners with orthobiologics company
Johnson & Johnson is partnering with Pacira BioSciences for osteoarthritis of the knee, according to a July 22 news release. The agreement adds Zilretta, an injectable osteoarthritis treatment, to Johnson & Johnson’s portfolio.
Mayor Brandon Johnson signs order to snuff out smoking on CTA L trains
Johnson says he wants to put social workers at stops and launch an anti-smoking campaign. A council member who’s pushed for enforcement against smoking says the mayor’s ideas could lack teeth.
Johnson & Johnson's Healthy 3.3%-Yielding Dividend Is a Very Safe Way to Make Passive Income
The healthcare company's payout currently yields 3.3%, more than double the S&P 500 's ( ^GSPC 0.32%) dividend yield (near a record low at around 1.2%). That high-yielding payout is very healthy, making Johnson & Johnson a very safe way to collect dividend income.
Mind Reading: Josh Johnson Takes ‘The Daily Show’ Host Gig While Riding Viral Wave For Healing Men’s Loneliness
As Josh Johnson slides into the host chair at "The Daily Show" this week, he's riding a viral wave for his stand-up set focused on healing loneliness among men.
Johnson & Johnson (JNJ)’s Pasritamig Shows Breakthrough Promise in Prostate Cancer
We recently published 10 Most Undervalued Pharma Stocks To Buy Now. Johnson & Johnson stands second among the most undervalued stocks. Johnson & Johnson (NYSE:JNJ) is a global healthcare leader with a diverse portfolio across pharmaceuticals,
Feedback